Cargando…
PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer
Purpurin 18 derivatives with a polyethylene glycol (PEG) linker were synthesized as novel photosensitizers (PSs) with the goal of using them in photodynamic therapy (PDT) for cancer. These compounds, derived from a second-generation PS, exhibit absorption at long wavelengths; considerable singlet ox...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943672/ https://www.ncbi.nlm.nih.gov/pubmed/31817655 http://dx.doi.org/10.3390/molecules24244477 |
_version_ | 1783484929606156288 |
---|---|
author | Pavlíčková, Vladimíra Rimpelová, Silvie Jurášek, Michal Záruba, Kamil Fähnrich, Jan Křížová, Ivana Bejček, Jiří Rottnerová, Zdeňka Spiwok, Vojtěch Drašar, Pavel Ruml, Tomáš |
author_facet | Pavlíčková, Vladimíra Rimpelová, Silvie Jurášek, Michal Záruba, Kamil Fähnrich, Jan Křížová, Ivana Bejček, Jiří Rottnerová, Zdeňka Spiwok, Vojtěch Drašar, Pavel Ruml, Tomáš |
author_sort | Pavlíčková, Vladimíra |
collection | PubMed |
description | Purpurin 18 derivatives with a polyethylene glycol (PEG) linker were synthesized as novel photosensitizers (PSs) with the goal of using them in photodynamic therapy (PDT) for cancer. These compounds, derived from a second-generation PS, exhibit absorption at long wavelengths; considerable singlet oxygen generation and, in contrast to purpurin 18, have higher hydrophilicity due to decreased logP. Together, these properties make them potentially ideal PSs. To verify this, we screened the developed compounds for cell uptake, intracellular localization, antitumor activity and induced cell death type. All of the tested compounds were taken up into cancer cells of various origin and localized in organelles known to be important PDT targets, specifically, mitochondria and the endoplasmic reticulum. The incorporation of a zinc ion and PEGylation significantly enhanced the photosensitizing efficacy, decreasing IC(50) (half maximal inhibitory compound concentration) in HeLa cells by up to 170 times compared with the parental purpurin 18. At effective PDT concentrations, the predominant type of induced cell death was apoptosis. Overall, our results show that the PEGylated derivatives presented have significant potential as novel PSs with substantially augmented phototoxicity for application in the PDT of cervical, prostate, pancreatic and breast cancer. |
format | Online Article Text |
id | pubmed-6943672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69436722020-01-10 PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer Pavlíčková, Vladimíra Rimpelová, Silvie Jurášek, Michal Záruba, Kamil Fähnrich, Jan Křížová, Ivana Bejček, Jiří Rottnerová, Zdeňka Spiwok, Vojtěch Drašar, Pavel Ruml, Tomáš Molecules Article Purpurin 18 derivatives with a polyethylene glycol (PEG) linker were synthesized as novel photosensitizers (PSs) with the goal of using them in photodynamic therapy (PDT) for cancer. These compounds, derived from a second-generation PS, exhibit absorption at long wavelengths; considerable singlet oxygen generation and, in contrast to purpurin 18, have higher hydrophilicity due to decreased logP. Together, these properties make them potentially ideal PSs. To verify this, we screened the developed compounds for cell uptake, intracellular localization, antitumor activity and induced cell death type. All of the tested compounds were taken up into cancer cells of various origin and localized in organelles known to be important PDT targets, specifically, mitochondria and the endoplasmic reticulum. The incorporation of a zinc ion and PEGylation significantly enhanced the photosensitizing efficacy, decreasing IC(50) (half maximal inhibitory compound concentration) in HeLa cells by up to 170 times compared with the parental purpurin 18. At effective PDT concentrations, the predominant type of induced cell death was apoptosis. Overall, our results show that the PEGylated derivatives presented have significant potential as novel PSs with substantially augmented phototoxicity for application in the PDT of cervical, prostate, pancreatic and breast cancer. MDPI 2019-12-06 /pmc/articles/PMC6943672/ /pubmed/31817655 http://dx.doi.org/10.3390/molecules24244477 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pavlíčková, Vladimíra Rimpelová, Silvie Jurášek, Michal Záruba, Kamil Fähnrich, Jan Křížová, Ivana Bejček, Jiří Rottnerová, Zdeňka Spiwok, Vojtěch Drašar, Pavel Ruml, Tomáš PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer |
title | PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer |
title_full | PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer |
title_fullStr | PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer |
title_full_unstemmed | PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer |
title_short | PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer |
title_sort | pegylated purpurin 18 with improved solubility: potent compounds for photodynamic therapy of cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943672/ https://www.ncbi.nlm.nih.gov/pubmed/31817655 http://dx.doi.org/10.3390/molecules24244477 |
work_keys_str_mv | AT pavlickovavladimira pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer AT rimpelovasilvie pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer AT jurasekmichal pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer AT zarubakamil pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer AT fahnrichjan pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer AT krizovaivana pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer AT bejcekjiri pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer AT rottnerovazdenka pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer AT spiwokvojtech pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer AT drasarpavel pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer AT rumltomas pegylatedpurpurin18withimprovedsolubilitypotentcompoundsforphotodynamictherapyofcancer |